FDA Approves Durvalumab for Muscle Invasive Bladder Cancer By Ogkologos - May 2, 2025 388 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the NIAGARA study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer ESMO Calls for Robust EU Taxation of Tobacco Products, Aiming to Prevent Cancers Attributable to Tobacco Use Aiming to Prevent Cancer Cases, ESMO Campaigns Against the Use of ‘Low-Alcohol’ Labelling in Response to the Council Agreement on the EU’s Wine Package MOST POPULAR PICOS Score May Help in Identification of Patients with Brain Metastasis... June 24, 2020 High Response Rates Observed Following KTE-X19 CAR T-Cell Therapy in Adults... June 15, 2021 Fears breast cancer progress could stall due to COVID-19 backlog June 15, 2021 Different Microbiota–Host Relationships Relevant to Distinct Immune Checkpoint Blockade Regimens March 21, 2024 Load more HOT NEWS For Kids with Medulloblastoma, Trial Suggests Radiation Can Be Tailored Medicare Open Enrollment is Almost Here-What You Need to Know for... Baby Boy Can’t Stop Smiling After Surgery Allows Him To See... Fertility Preservation Safe for Young Women with Breast Cancer
